New Enterprise Associates

New Enterprise Associates is a venture capital firm founded in 1977 and based in Menlo Park, California, with offices in the United States, India and China. It makes investments across technology and healthcare startups at multiple stages, from seed to growth, including software, cloud, data, internet services, fintech, AI, e-commerce, and enterprise technology, as well as healthcare information technology, life sciences, medical devices, and biopharma. It also considers energy technology and infrastructure opportunities, such as solar, batteries and smart grids. The firm pursues a global approach, with activity in the United States, Asia and other regions, and supports companies through rounds of financing ranging from small to sizable investments as they scale. NEA focuses on building portfolios in software, IT services, consumer technology, and healthcare technology, backing ambitious entrepreneurs across sectors and geographies.

Michael Albert

Associate

Kate Barrett

Partner, Communications

James Buxton MD

Principal

Pamela Clark

General Partner

Vanessa Deng

Associate

Chris Doppman

Managing Director, LP Relations

Jay Graf

Venture Partner

Arjun Jain

Senior Associate

Nick Kline

Partner, LP Relations

Mohamad Makhzoumi

General Partner, Global Head of Healthcare Services

Jake Nunn

Partner

Greg Papadopoulos

Venture Partner

Arno Penzias Ph.D

Venture Partner

Tim Schaller

CFO

George Stamas

Venture Partner

Brad Thawley

Partner, Limited Partner Relations

Lulu Xu

Principal

Edison Zhang

Associate

Past deals in Series A

Glacier

Series A in 2025
Glacier develops AI-enabled recycling robots for recycling facilities. Founded in 2019 and headquartered in San Francisco, California, the company creates affordable, high-performing, and space-efficient robots that automate the sorting of recyclable materials. Its platform combines artificial intelligence-powered sensors and robotics to streamline operations, improve sorting accuracy, and increase profitability for waste facilities.

Aetherflux

Series A in 2025
Aetherflux is an aerospace company focused on providing renewable energy solutions to households, businesses, and military operations worldwide. The company has developed an innovative design for space-based solar power, which entails a constellation of small satellites that harness sunlight, convert it into electricity, and wirelessly transmit the power to ground stations. This technology aims to deliver reliable energy distribution while minimizing environmental impact, positioning Aetherflux at the forefront of the renewable energy sector.

Cambium Carbon

Series A in 2025
Cambium Carbon is an early-stage social enterprise focused on natural climate solutions through reforestation and urban wood reuse. It partners with cities and other public and private stakeholders to divert urban wood waste from landfills, repurpose fallen city trees for reuse, and channel revenues into planting and maintenance projects. It operates reforestation hubs that create a circular economy for urban forests, reclaiming city wood waste and building local regenerative supply chains, with the aim of reducing climate impact while creating jobs and strengthening urban resilience.

Music AI

Series A in 2025
Music AI is a software company specializing in artificial intelligence solutions for music and audio technology. It offers musicians and producers a suite of AI tools including audio separation, pitch/chord detection, metronome, tempo changer, and mastering.

Ouro Medicines

Series A in 2025
Ouroboros Medicines is a biotechnology company dedicated to immunology, focusing on treating chronic immune-mediated illnesses. It specializes in developing immune reset treatments, using a therapeutic platform that employs T cell engager antibodies to target and deplete specific pathogenic cells. This approach aims to provide extended remissions for patients, without the need for ongoing immunosuppression. The company's strength lies in its integration of scientific knowledge and proven track record in progressing cell-depleting treatments through clinical trials, supported by a robust pipeline.

Orbis Medicines

Series A in 2025
Orbis Medicines is a company that develops a macrocyclic chemistry and computational platform for oral macrocycle drug discovery. The platform generates macrocycle candidates, nCycles, optimized for oral bioavailability to advance therapeutics that historically faced development hurdles. Its pipeline centers on nCycle candidates targeting validated biologic targets that are typically addressed by injectable drugs, with the goal of enabling oral delivery of such therapies. The platform combines chemistry and computational methods to accelerate drug discovery toward challenging targets in unmet-need indications, supporting therapeutics designed to improve patient outcomes.

Backflip AI

Series A in 2024
Backflip AI operates a platform that combines human creativity with 3D generative AI, enabling engineers and designers to work efficiently and produce highly realistic models. These models can be used in various applications, such as 3D printing, video game assets, renders, and digital media, as well as in the design of physical structures like buildings and automobiles. The company's technology aims to accelerate design processes and provide businesses with a competitive edge.

Avenzo Therapeutics

Series A in 2024
Avenzo Therapeutics focuses on developing innovative cancer treatments. It operates a clinical-stage platform dedicated to creating novel therapies for underserved cancers, with a pipeline targeting rare and genomically defined cancers.

Genmo

Series A in 2024
Genmo is a technology company that develops an artificial intelligence platform for creative content generation. Its platform enables users to create high-quality videos, images, and 3D models using intuitive text and image prompts, leveraging advanced natural language processing technology. This allows video creators to generate custom visual media and produce cinematic video content with the assistance of AI.

Firestorm

Series A in 2024
Firestorm develops modular open-source unmanned aerial platforms and related hardware and software designed for defense applications. The company focuses on open-architecture systems that enable rapid, distributed manufacturing and mission-adaptable configurations. Its platforms feature swappable propulsion and payload options and are supported by mobile micro-factories that enable rapid drone production through advanced additive manufacturing. By enabling customizable, low-cost aerial systems, Firestorm aims to support military and defense operators across varied terrains and missions with adaptable, scalable solutions.

DeltaStream

Series A in 2024
DeltaStream offers a unified self-service platform for stream processing powered by Apache Flink. It enables real-time analytics, efficient scaling, and robust data governance, allowing organizations to harness the power of their streaming data effectively.

Sakana AI

Series A in 2024
Sakana AI is a research-focused company dedicated to developing innovative foundation models inspired by nature. It specializes in creating an AI model capable of generating text, images, video, code, and multimedia, facilitating collaborative research and development in generative AI. The company's AI development process emphasizes evolution and collective intelligence.

Amber Therapeutics

Series A in 2024
Amber Therapeutics specializes in developing advanced bioelectronic therapies that can sense and adapt, aiming to enhance clinical outcomes for patients with functional disorders of the peripheral nervous system.

Twelve Labs

Series A in 2024
Twelve Labs offers a platform that empowers businesses and developers to analyze and interpret video content through multiple modalities like visual and auditory data. This enables the creation of intelligent video applications across industries such as technology, media, entertainment, and security.

Xaira Therapeutics

Venture Round in 2024
Xaira Therapeutics is a biotechnology company that leverages artificial intelligence to revolutionize drug discovery and development. Headquartered in the San Francisco Bay Area, Xaira brings together machine learning experts, expansive data generation, and robust therapeutic product development to advance treatments for various diseases.

AI Squared

Series A in 2024
AI Squared helps large organizations bring AI to where work happens. We do this by leveraging our SaaS or on-prem platform which combines data sources with advanced AL/ML functionality and embeds intelligent insights into critical business applications. Trusted by the largest financial institutions, the most complicated supply chain logistics companies, and the US Department of Defense, we enable seamless collaboration between data science teams and business users, driving faster, more informed decision-making.

Avenzo Therapeutics

Series A in 2024
Avenzo Therapeutics focuses on developing innovative cancer treatments. It operates a clinical-stage platform dedicated to creating novel therapies for underserved cancers, with a pipeline targeting rare and genomically defined cancers.

Foundry

Series A in 2024
Foundry is a public cloud supported by an orchestration platform designed to simplify the utilization of AI computing resources. Foundry addresses fundamental economic and technical obstacles encountered in AI and deep learning. Current challenges faced by businesses, such as the notable GPU scarcity and inefficient use of computing capabilities, hinder their effective utilization of resources. Foundry employs pioneering approaches to overcome these hurdles, offering scalable GPU instances with unparalleled price-performance ratios.

Together AI

Series A in 2024
Together is a technology services platform that offers a decentralized cloud specifically for artificial intelligence development. The company focuses on constructing open-source generative AI models and infrastructure, providing tools and resources that enable developers and researchers to train, refine, and deploy these models efficiently. Together's platform emphasizes accessibility and user-friendliness, allowing organizations of various sizes to leverage and enhance AI capabilities. By contributing innovative open-source research, models, and datasets, Together plays a significant role in advancing the field of AI and fostering collaborative development efforts.

Mojo Vision

Series A in 2023
Founded in 2015, Mojo Vision specializes in developing and commercializing advanced micro-LED display technology for various applications. The company is renowned for creating the world's smallest dynamic display for augmented reality smart contact lenses. Headquartered in Saratoga, California, Mojo Vision aims to disrupt the $160 billion display industry with its proprietary quantum-dot technology.

Rocket.Chat

Series A in 2023
Rocket.Chat Holdings, Ltd., established in 2015, specializes in developing and operating an open-source web chat platform. The company offers a comprehensive suite of features, including video conferencing, helpdesk chat, file sharing, and screen sharing, along with API and native mobile applications. Rocket.Chat also provides white labeling, integrations, and hosting services. With over 500,000 servers installed and 12 million users worldwide, the platform facilitates internal and external communication within a secure environment. Users can run Rocket.Chat on-premises or on the cloud, tailoring the platform with features like individual and group communication, video conferencing, and integration with various external communications platforms. The company's long-term vision is to replace email with a real-time, federated communications platform and foster a marketplace for app-building and services.

Nexo Therapeutics

Series A in 2023
Nexo Therapeutics is a small molecule oncology company focused on discovering and developing innovative drugs for cancer patients who have limited therapeutic options. The company utilizes a unique platform that integrates covalent ligand discovery and chemical biology, allowing it to advance small-molecule therapies aimed at challenging and previously intractable cancer targets. By unlocking a pipeline of novel oncology treatments, Nexo Therapeutics seeks to provide medical professionals with new and effective options to improve patient outcomes in the fight against cancer.

Tagworks Pharmaceuticals

Series A in 2023
Tagworks Pharmaceuticals is a privately held biotech company based in the Netherlands, established in 2011 as a spin-out from Philips Healthcare. The company focuses on developing innovative in vivo chemistry to enhance the effectiveness of cancer therapies and to facilitate novel companion diagnostics. Operating from the Radboud University Medical Center in Nijmegen, Tagworks specializes in antibody-based imaging and therapy technologies. Its proprietary approach allows for the selective chemical manipulation of tagged antibodies in vivo, which improves the efficacy of established methods like radioimmuno-imaging and antibody-drug conjugates. This technology enables medical professionals to conduct imaging with significantly reduced radiation exposure for patients.

Djust

Series A in 2023
Djust provides a cloud‑based B2B platform that accelerates the launch of e‑commerce and e‑procurement solutions. The integrated product combines digital showrooms, an online marketplace, and customer relationship management tools, enabling businesses to build, upgrade, and expand their online operations efficiently.

Granica

Series A in 2023
Granica is a company that specializes in enhancing the efficiency and safety of artificial intelligence applications through its AI Data Readiness Platform. This platform assists data engineers and leaders in creating AI-ready data, which is crucial for optimizing machine learning models and analytics. By improving the efficiency of tabular and natural language processing training data, Granica significantly reduces storage costs and enhances query performance. The company focuses on mitigating risks associated with sensitive data leakage and harmful content, thereby ensuring privacy and safety in AI inputs and outputs. Granica curates and refines training datasets to select impactful samples, ultimately boosting the performance and reliability of AI models. Targeting enterprises in data-intensive sectors such as financial services, retail, geo-spatial intelligence, and autonomous vehicles, Granica enables clients to leverage AI more effectively, enhancing trust and improving business outcomes.

Union.ai

Series A in 2023
Union.ai is a Kubernetes-native workflow orchestration platform for data and machine learning at scale. Union.ai provides software users with the tools they need to move their ideas from concept to high-quality production. Union's aim is to organize the numerous processes required to train and grow the most sophisticated and dynamic machine learning and data products.

Limitless

Series A in 2023
Limitless is a technology company focused on developing advanced artificial intelligence solutions. They develop AI-driven products to improve productivity, streamline processes, and deliver insights for businesses. Limitless serves a broad range of industries, from retail and finance to healthcare and logistics, providing AI solutions that are tailored to the unique needs of each sector.

Kira

Venture Round in 2023
Kira Learning is an AI-driven education technology company that creates innovative tools and solutions to support educators and students. Its primary mission is to empower schools, districts, and teachers by integrating cutting-edge artificial intelligence into educational practices, making teaching more effective and learning more engaging.

Kindred

Series A in 2023
Kindred is an exclusive network facilitating non-cash home swapping among its members. Each member must host their own property to participate, fostering trust and reciprocity.

SimpleRose

Venture Round in 2023
SimpleRose Inc. is a technology company based in Saint Louis, Missouri, that specializes in developing a prescriptive analytics platform aimed at enhancing decision-making in complex environments. Founded in 2018, the company offers solutions that optimize and accelerate processes such as scheduling, production planning, and portfolio optimization. By leveraging advanced algorithmic innovations, SimpleRose’s platform provides high levels of numerical accuracy, speed, and the capability for continuous analysis, enabling organizations to effectively address operational challenges and make informed decisions.

Perplexity

Series A in 2023
Perplexity is an AI-driven search engine platform that combines large language models with traditional search engines. It uses natural language processing (NLP) and generative AI to provide conversational responses, bridging the gap between conventional search engines and interactive AI assistance.

OP3N

Series A in 2023
Founded in 2021, OP3N is a global Web3 superapp that serves as a one-stop-shop for communication, connection, and commerce with on-chain interactions. It aims to create a more frictionless, decentralized, and democratized creator economy by consolidating tools needed for minting, sharing, and engaging with digital goods and tokens into one unified interface. Co-led by Jaeson Ma and Eric Tu, OP3N is headquartered in Los Angeles.

Flox

Series A in 2023
Flox develops a web application that enhances developer productivity throughout the software development lifecycle. The company offers SaaS products that leverage Nix, allowing enterprises to install packages, manage development and production environments, and ensure consistent software deployment across embedded devices. By enabling developers to treat environments and packages as code, Flox streamlines the process of building and managing software, promoting efficiency and reliability in development practices.

Launchpad Therapeutics

Series A in 2022
Launchpad Therapeutics is an antibody-focused precision oncology company.

Fizz

Series A in 2022
Fizz is an authorized platform designed to enhance community social structures, particularly within institutions. It develops online social media software that facilitates communication and the sharing of ideas, events, and experiences among users. The platform allows individuals to post secret confessions and ask questions within a closed community, promoting social interaction while maintaining anonymity. By leveraging these features, Fizz aims to foster a more connected and engaged community environment.

Partiful

Series A in 2022
Partiful is an online party planning platform that helps users plan, invite, and communicate with guests, including inviting friends of friends when contact details are unavailable. The service aims to simplify organizing social events and cultivating real-world friendships by facilitating invitations and coordination for various gatherings, from intimate dinners to larger events. By providing tools to streamline guest management and messaging, Partiful supports users in fostering in-person relationships and creating memorable social experiences.

Bliq

Series A in 2022
Bliq GmbH, established in 2019 and headquartered in Berlin, Germany, specializes in developing application software for gig workers in the transport industry. Its flagship product, Bliq Ride, enables registered drivers to automate their daily tasks by accepting or rejecting orders from multiple platforms simultaneously. The company's mission is to streamline work organization for rideshare and delivery drivers using traffic data, technology, and collective intelligence. As of now, Bliq employs 25 people.

PixieBrix

Series A in 2022
PixieBrix is a low-code platform that enables rapid customization and automation of web tools. It leverages AI technology to optimize workflows, enhancing productivity for users ranging from entrepreneurs to large organizations. PixieBrix offers enterprise-ready extensions that can be tailored to specific needs, seamlessly integrating into any website.

QuoteWell

Series A in 2022
Founded in 2021, QuoteWell is a digital platform designed for the insurance industry. Based in Austin, Texas, it offers an integrated submission process that securely transmits insured applications to underwriters and enables agents and brokers to access modern risk transfer infrastructure.

Arkestro

Series A in 2022
Arkestro is a technology company specializing in predictive procurement software designed to enhance savings and supply chain performance for businesses. Their platform pre-embeds preferred outcomes into any system or process, allowing companies to orchestrate activities across various systems using instant forecasts and real-time collaboration. By leveraging artificial intelligence, Arkestro's cloud-based automated negotiation software optimizes procurement savings and increases vendor participation, leading to significant cost reductions in managed services and raw materials solicitations.

Code Biotherapeutics

Series A in 2022
Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies to treat serious and life-threatening genetic diseases. Code Bio leverages its novel multivalent synthetic DNA delivery platform, 3DNA, which has been engineered to overcome many of the challenges inherent with viral-based gene therapies such as immunogenicity, size and delivery limitations, re-dosability, and manufacturing complexity. The company is advancing an internal pipeline focused on select rare disease programs as well as establishing partnerships to take forward programs in both rare and prevalent diseases.

Bliq

Series A in 2022
Bliq GmbH, established in 2019 and headquartered in Berlin, Germany, specializes in developing application software for gig workers in the transport industry. Its flagship product, Bliq Ride, enables registered drivers to automate their daily tasks by accepting or rejecting orders from multiple platforms simultaneously. The company's mission is to streamline work organization for rideshare and delivery drivers using traffic data, technology, and collective intelligence. As of now, Bliq employs 25 people.

Jomboy Media

Series A in 2022
Jomboy Media operates an online platform dedicated to producing and distributing original content centered around sports and pop culture. Their offerings include podcasts, digital series, and television shows, empowering creators to generate engaging content within these realms.

Wheelhouse

Series A in 2022
Founded in 2014, Wheelhouse develops a software platform for property owners and hosts in the short-term rental industry. Its core product, data-driven pricing, empowers users to optimize revenue and bookings by analyzing local market trends and optimizing pricing strategies.

NODAR

Series A in 2022
Founded in 2018, NODAR specializes in developing camera-based 3D vision systems for autonomous vehicles. Its flagship product, Hammerhead, uses off-the-shelf cameras to deliver long-range, depth-sensing capabilities, enhancing safety features like forward collision warning and automatic emergency braking.

Evernow

Series A in 2022
Evernow offers comprehensive women's healthcare services focused on menopause. Their platform provides online access to specialized doctors, evidence-based information, treatments, and supportive communities, empowering women to manage hormonal changes and improve their overall health.

Antimatter

Series A in 2022
Antimatter is a company that provides cryptographic infrastructure services aimed at enhancing data security for B2B SaaS businesses. Founded in 2021 and located in Oakland, California, Antimatter's technology utilizes secure enclaves found in major cloud platforms to transparently encrypt customer data. This approach allows clients to adhere to stringent data security and privacy standards without necessitating any modifications to their existing code. By addressing the critical challenges of data security, Antimatter offers a solution that streamlines the protection of sensitive information for its customers.

Clockwork Systems

Series A in 2022
Clockwork Systems specializes in technology that enhances time-sensitive applications across on-premises data centers, public clouds, and hybrid environments. The company develops cloud management synchronization solutions that deliver ultra-accurate and scalable time services. By assessing network latency, Clockwork Systems optimizes application performance, enabling businesses to carry out critical functions like precise timestamping and the sequential execution of trades. This technology addresses fundamental latency issues, ultimately increasing productivity for enterprises that rely on accurate timing for their operations.

SafeBase

Series A in 2022
SafeBase, Inc. is a San Francisco-based company founded in 2020 that specializes in cloud-based security software aimed at helping organizations establish and enhance their security programs. The company’s offerings include a smart trust center platform that facilitates the sharing of security posture and automates access to sensitive documents. SafeBase provides solutions such as SafeBase Inspected, which features a website badge linking to a custom security status page, as well as custom security checklists and continuous monitoring of security systems. Additionally, the software assists organizations in configuring security policies, thereby enabling them to implement robust security practices effectively.

Weaviate

Series A in 2022
Weaviate is a company that offers an open-source AI-native database and hybrid SaaS platform to build search and recommendation systems. Its vector search engine supports semantic search and integrates with applications via plugins and a console that helps understand data. The platform merges vector and keyword search to enable end-to-end AI-native application development, supporting synchronous, asynchronous, and multi-step data interactions.

Splice Bio

Series A in 2022
Splice Bio is a biotechnology company based in Barcelona, Spain, that specializes in developing innovative gene therapies using its proprietary intein platform technology. Founded in 2012, the company focuses on addressing the needs of patients suffering from incurable genetic diseases. Splice Bio's technology, originally developed in the Muir Lab at Princeton University, enhances the capabilities of traditional adeno-associated viruses (AAVs) by allowing for larger gene cargo delivery and targeting a broader range of tissues. This advancement aims to overcome existing limitations in gene therapy, making it a promising solution for treating complex genetic disorders. The company was formerly known as Proteodesign, S.L. before rebranding to Splice Bio in September 2020.

FTX US Derivatives

Series A in 2022
FTX US is a bitcoin options exchange designed to assist both individual traders and institutions in trading. FTX US allows users to trade a variety of digital assets like Bitcoin, Ethereum, Solana, and Dogecoin. The company was founded by Sam Bankman-Fried and Gary Wang in 2020 and is based in San Francisco, California.

Waymark

Series A in 2022
Waymark is a healthcare company focused on improving access to and quality of care for Medicaid beneficiaries. It delivers community-based services and collaborates with primary care providers to enhance access and health outcomes for patients enrolled in Medicaid. The company provides health plans, insulin education, and training, and creates employment opportunities for community-based care teams, supporting coordinated care and patient engagement so beneficiaries can monitor and manage their health.

Sorriso Pharmaceuticals

Series A in 2021
Founded in 2020 and headquartered in San Diego, California, Sorriso Pharmaceuticals is a biotechnology company dedicated to developing disease-modifying antibodies for treating inflammatory diseases such as Crohn's disease and ulcerative colitis. Its proprietary platform generates potent antibodies designed for oral delivery, aiming to maintain therapeutic activity throughout the intestinal system.

Belong Health

Series A in 2021
Belong Health collaborates with local health plans to deliver regionally tailored, personalized care to a growing community of individuals eligible for Medicare Advantage and dual-eligible special needs plans.

Wonder

Series A in 2021
Wonder is a technology company that develops an all-in-one gaming platform for Android mobile devices. The platform enables users to play, stream, and share games across devices seamlessly.

Tune Therapeutics

Series A in 2021
Tune Therapeutics develops cell and gene therapies guided by epigenetic programming to treat devastating diseases. The company is building an epigenetic programming platform that enables new pathways for disease treatment by tapping into the epigenome to program biology without altering the DNA sequence. This approach aims to deliver paradigm-changing therapies by modulating gene expression through epigenetic mechanisms rather than editing the genome, expanding options for diseases where conventional treatments have limited efficacy. By integrating epigenetics and cell biology, the company seeks durable, precise interventions that can reprogram cellular states to restore function while minimizing genetic change. The emphasis is on research and development to advance candidates toward clinical use to address severe and unmet medical needs.

AviadoBio

Series A in 2021
AviadoBio focuses on developing transformative gene therapies for devastating neurodegenerative disorders such as frontotemporal dementia and amyotrophic lateral sclerosis. The company's platform combines proprietary technologies with a deep understanding of the brain to deliver effective treatments.

Prelay

Series A in 2021
Prelay streamlines sales processes by coordinating deal-related communication among revenue teams and internal stakeholders through its integrated platform. This enhances efficiency, reduces deal slippage, and provides leaders with insights into resource utilization.

Recludix Pharma

Series A in 2021
Recludix Pharma develops a platform for discovering potent and selective inhibitors of complex protein targets. The platform integrates custom-generated DNA-encoded libraries, massively parallel structure-activity relationship determination, and proprietary screening tools to ensure selectivity.

Datafold

Series A in 2021
Datafold is a software company that automates analytical data quality management. Its platform enables instant table comparisons, data profiling, and automated validation of ETL changes and data transfers. It supports monitoring and QA across data pipelines and integrates with data engineering workflows to streamline data quality processes. The goal is to help organizations extract more value from analytical data by ensuring accuracy, consistency, and reliability of data used for analytics and decision-making. Founded in 2020 and based in San Francisco, California, Datafold provides tools that simplify data QA and automate data engineering tasks.

Merge

Series A in 2021
Merge simplifies secure data access by offering Unified APIs across key software categories like HRIS, accounting, CRM, and file storage. It handles the entire integration lifecycle, from initial build to maintenance, enabling thousands of companies to unblock sales, reduce churn, accelerate product launch, and save engineering resources.

Candy Digital

Series A in 2021
Founded in 2021 by Fanatics, Michael Rubin, Mike Novogratz, and Gary Vaynerchuk, Candy Digital is a rapidly growing company specializing in non-fungible tokens (NFTs), enabling fans to buy, sell, and trade officially licensed digital collectibles. The company offers a wide range of digital assets, initially focusing on sports content before expanding into art, entertainment, and music.

Wizard

Series A in 2021
Founded in 2021, Wizard is a New York-based software company specializing in B2B solutions. It leverages conversational AI technology to enable brands to sell and market products directly through text messaging, enhancing customer engagement and conversion rates.

Slope.io

Series A in 2021
Slope.io, Inc. is a company that specializes in clinical trial logistics, catering to sponsors, contract research organizations (CROs), and research sites throughout the United States. Founded in 2016 and based in Mobile, Alabama, Slope.io offers a platform that streamlines the operational complexities associated with clinical trials. Its Slope.io Coordination service converts logistics requirements into organized schedules and workflows, while the Slope.io Kitting service provides customizable supply kits tailored to specific sites, patients, or study time points. The company emphasizes real-time coordination and complete traceability of devices, drugs, and kits from suppliers to research sites and patients.

Neural Magic

Series A in 2021
Neural Magic specializes in enterprise inference solutions that optimize the performance of open-source large language models across various infrastructures. The company focuses on maximizing computational efficiency and hardware utilization, enabling organizations to deploy AI models securely and cost-effectively.

858 Therapeutics

Series A in 2021
858 Therapeutics is a biotechnology company specializing in the discovery of small molecule therapeutics for novel targets in oncology and immunology. The company focuses on innovative approaches such as synthetic lethality, innate immunity, and RNA modulation, with its lead program being a PARG inhibitor currently in early clinical development.

Workera

Series A in 2021
Workera is a precision upskilling platform that enables enterprises, governments, and individuals to enhance their technological capabilities in areas such as data science, machine learning, and artificial intelligence. The platform utilizes AI-driven assessments and personalized learning plans to provide targeted mentorship and facilitate skill development. By offering an objective analysis of workforce skills, Workera helps organizations identify and mobilize talent effectively. Its approach includes measuring skills at a granular level, allowing for hyper-personalized learning experiences that drive measurable results. This capability equips organizations with actionable data, enabling them to make informed decisions regarding talent acquisition, mobility, coaching, and mentoring, ultimately addressing the critical skills gap in today's rapidly evolving technological landscape.

Vori Health

Series A in 2021
Vori Health offers an integrated medical practice specializing in treating musculoskeletal conditions. Its nationwide, evidence-based approach addresses back, neck, and joint issues through a unique, virtual-first care model. Patients are connected to a collaborative team consisting of a board-certified physician, health coach navigator, and physical therapist for comprehensive care.

Stablix

Series A in 2021
Stablix Therapeutics is a biotechnology company specializing in Targeted Protein Stabilization (TPS). It develops heterobifunctional small molecules that recruit deubiquitinase enzymes to stabilize or enhance targeted proteins, focusing on treating rare diseases, cancer, and immunological disorders.

Vori Health

Series A in 2021
Vori Health offers an integrated medical practice specializing in treating musculoskeletal conditions. Its nationwide, evidence-based approach addresses back, neck, and joint issues through a unique, virtual-first care model. Patients are connected to a collaborative team consisting of a board-certified physician, health coach navigator, and physical therapist for comprehensive care.

Rapid Robotics

Series A in 2021
Rapid Robotics is a provider of industrial automation solutions focused on robotic arms and palletizing systems for manufacturing and logistics. The company develops and deploys affordable robotic workcells and software that combine AI and vision-based capabilities to handle a range of palletizing and material-handling tasks. Its offerings enable rapid deployment, often in hours rather than weeks, and aim to lower operating costs while increasing production capacity, efficiency, and quality. Through a Robot-as-a-Service model, Rapid Robotics helps sites scale automation without the burden of ownership or extensive custom programming. Founded in 2019 and headquartered in San Francisco, the company targets manufacturers facing labor shortages and rising fulfillment complexity by delivering flexible, service-driven automation that improves margins and throughput.

Goody

Series A in 2021
Goody is a corporate gifting platform that simplifies the process of sending gifts, making it as effortless as sending a text message. The company offers a curated selection of gifts, including robes, cookies, succulents, and spa treatments, which can be chosen without needing the recipient's size information. Recipients have the flexibility to select their preferred size or type of gift or exchange it for another option of similar value. Goody's payment system is designed to enhance user experience, as payments are only processed once the gift is received, ensuring a more personal and considerate gifting experience for both businesses and individuals.

Theorycraft Games

Series A in 2021
Theorycraft Games operates as an independent game development studio that operates remotely. The company is in process of developing its first game codenamed Loki. Theorycraft was founded in 2020 and is headquartered in Los Angeles, California, United States.

Rocket.Chat

Series A in 2021
Rocket.Chat Holdings, Ltd., established in 2015, specializes in developing and operating an open-source web chat platform. The company offers a comprehensive suite of features, including video conferencing, helpdesk chat, file sharing, and screen sharing, along with API and native mobile applications. Rocket.Chat also provides white labeling, integrations, and hosting services. With over 500,000 servers installed and 12 million users worldwide, the platform facilitates internal and external communication within a secure environment. Users can run Rocket.Chat on-premises or on the cloud, tailoring the platform with features like individual and group communication, video conferencing, and integration with various external communications platforms. The company's long-term vision is to replace email with a real-time, federated communications platform and foster a marketplace for app-building and services.

Narmi

Series A in 2021
Narmi Inc. is a technology company that specializes in developing online and mobile banking applications for financial institutions across the United States. Founded in 2016 and headquartered in New York, Narmi provides a comprehensive platform that allows regional and community banks and credit unions to attract, engage, and retain customers effectively. The company’s applications facilitate account openings in under 2.5 minutes, while ensuring a secure and user-friendly experience through features such as fraud protection, multi-factor authentication, and transaction monitoring. In addition to banking applications, Narmi also offers services in website design, development, hosting, and content management, helping financial institutions create a dynamic and engaging digital presence.

New Wave Foods

Series A in 2021
New Wave Foods, Inc., established in 2015 and headquartered in San Francisco, specializes in producing and selling plant-based seafood products. The company offers a range of shrimp alternatives, including sautéed, grilled, breaded, and fried options, as well as shrimp tacos and salads. These products are made from sustainably sourced seaweed, soy protein, and natural flavors, providing a sustainable and healthier alternative to traditional seafood. New Wave Foods serves customers in the culinary market across the United States, positioning itself as a leader in sustainable seafood.

Polyneuron Pharmaceuticals

Series A in 2020
Polyneuron Pharmaceuticals AG is a biopharmaceutical company based in Basel, Switzerland, focused on developing innovative therapeutics for the treatment of autoimmune disorders. Founded in 2014, the company specializes in creating drugs to target specific autoimmune conditions, including PN-1007 for anti-MAG neuropathy, PN-1018 for multifocal motor neuropathy, and PN-032 and PN-056 for ABO-incompatible transplantation. Polyneuron's therapeutic approach employs biodegradable glycopolymers that selectively eliminate pathological autoantibodies, preserving the overall integrity of the immune system. This technology, referred to as Antibody-Catch, aims to provide safe and effective treatment options for patients suffering from autoimmune diseases affecting the peripheral nervous system, particularly those involving autoantibodies against carbohydrate epitopes.

Korro Bio

Series A in 2020
Korro Bio Inc., established in 2018 and headquartered in Cambridge, Massachusetts, specializes in developing nucleic acid-based therapeutics targeting specific sequences in genetic code to treat rare diseases. The company's proprietary platform enables efficient and selective RNA editing, leveraging natural processes common to all multicellular organisms. Korro Bio aims to advance this technology to effect changes in protein structure and function across multiple tissues, expanding the reach of genetic medicines with additional precision and tunability by editing RNA instead of DNA.

GRID

Series A in 2020
GRID is a productivity tool that transforms everyday Excel spreadsheets into modern web applications, allowing users to create interactive web documents without requiring new skills. This platform offers an editor that automates the conversion process, enabling users to generate visually appealing and interactive web reports from their spreadsheets. Additionally, GRID facilitates secure sharing and analysis of these documents, empowering clients to turn traditional spreadsheets into dynamic dashboards or applications that enhance collaboration and usability.

MBX Biosciences

Series A in 2020
MBX Biosciences is a biotechnology company focused on developing therapies for endocrine and metabolic disorders, emphasizing rare endocrine diseases with limited treatment options. It pursues discovery, development, and commercialization of first-in-class peptide therapeutics that modulate glandular hormone signaling. MBX has developed a proprietary Precision Endocrine Peptide platform to engineer peptides with extended time-action profiles and consistent drug exposure, aiming to overcome limitations of traditional peptide therapies and improve disease management. Based in Carmel, Indiana, the company advances novel peptide programs through clinical development to address unmet medical needs in endocrine and metabolic disorders.

Monte Rosa Therapeutics

Series A in 2020
Monte Rosa Therapeutics is a biotechnology company focused on cancer therapeutics that target protein degradation pathways. It specializes in developing molecular glue degraders, a class of small molecules that direct disease-relevant proteins to degradation by the cell's natural machinery. The company uses its QuEEN platform, incorporating artificial intelligence and proprietary experimental tools, to identify target proteins for degradation by molecular glue degraders. It maintains a diverse library of more than 50,000 molecules and advancing its pipeline, including MRT-2359, a candidate that targets the translation termination factor GSPT1 for potential use in MYC-driven tumors.

Beyond Identity

Series A in 2020
Beyond Identity, Inc. is a New York-based company that specializes in cloud-native passwordless identity management solutions. Founded in 2019, it aims to enhance digital security by replacing traditional passwords with secure, X.509-based certificates. This innovative approach creates a robust Chain of Trust, incorporating user and device identity along with a real-time assessment of device security for adaptive authentication and authorization. Beyond Identity's platform facilitates frictionless login experiences through biometric authentication and seamless integration with Single Sign-On (SSO) systems, catering to employees, contractors, and customers alike. By eliminating the use of passwords, the company helps organizations mitigate risks associated with credential-stuffing attacks and streamline their authentication processes, ultimately enabling greater business agility and cost efficiency.

Vimaan

Series A in 2020
Vimaan is a technology company specializing in computer vision and AI solutions for warehouse inventory management. Their systems employ AI-powered cameras, autonomous drones, and machine learning algorithms to capture, digitize, and analyze inventory data across warehouses, enhancing inventory accuracy and reducing manual labor.

Affinia Therapeutics

Series A in 2020
Affinia Therapeutics develops adeno-associated virus (AAV) gene therapies for muscular and central nervous system diseases. The company uses an AAV vector design platform built on synthetic and systems biology, high-throughput screening, and tissue- and single-cell-resolution analyses to create vectors with improved properties. It leverages sequencing, artificial intelligence, and structural modeling to enable rational design of therapies. Headquartered in Waltham, Massachusetts, Affinia Therapeutics was founded in 2019 and targets diseases with significant unmet needs in muscle and CNS.

ClearMetal

Series A in 2020
ClearMetal, Inc. is a San Francisco-based company that specializes in artificial intelligence software for supply chain operations. Founded in 2014, it provides transport and supply chain visibility solutions through its cloud-based platform. The company leverages proprietary machine learning algorithms to enhance the accuracy and quality of freight data, enabling organizations to obtain real-time insights into shipment status, estimated arrival times, and potential delays. This advanced analytics capability allows shippers to manage exceptions efficiently and improve overall customer experience. ClearMetal's focus on delivering continuous visibility helps supply chain organizations optimize logistics and maintain easy access to reliable information about their shipments.

Dandelion Energy

Series A in 2020
Dandelion Energy, Inc. is a Palo Alto, California-based company founded in 2017 that specializes in affordable geothermal heating and cooling solutions. The company replaces traditional air conditioning and heating systems with an innovative home geothermal system that utilizes a powerful heat pump and underground pipes to transfer heat between the earth and the residence. This system is designed to harness thermal energy from below the earth's surface to regulate indoor temperatures and provide hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal alternative. Dandelion Energy is committed to making renewable heating and cooling accessible and cost-effective for homeowners.

Lily AI

Series A in 2020
Lily AI is an innovative e-commerce product discovery platform based in Mountain View, California, that focuses on enhancing the sales performance of brands and retailers. The company specializes in integrating customer-centric product attributes into various facets of the e-commerce ecosystem, including site search engines and recommendation systems. By aligning brand messaging with customer intent, Lily AI improves on-site search, personalized product discovery, and demand prediction. This approach enables retailers, particularly in the fashion, home, and beauty sectors, to achieve significant increases in traffic, conversion rates, revenue, and brand loyalty.

Anyscale

Series A in 2019
Anyscale develops and operates distributed programming platforms for simplifying distributed AI development. It offers Ray, an open-source framework enabling software developers and machine learning engineers to scale applications effortlessly from a laptop to the cloud.

Shape Therapeutics

Series A in 2019
Shape Therapeutics, Inc. is a biotechnology company focused on RNA-editing gene therapy for various medical conditions, including neurodegenerative disorders, oncology, metabolic diseases, and rare genetic disorders. Founded in 2018 and headquartered in Seattle, Washington, the company utilizes its proprietary RNAfix technology to edit RNA using the body’s natural cellular machinery. This approach minimizes risks associated with immunogenicity, cellular toxicity, and unintended DNA editing. Shape Therapeutics is dedicated to advancing its innovative platforms for payload, delivery, and manufacturing to enable the development of effective treatments, aiming to address critical health challenges and improve patient outcomes.

The Yes

Series A in 2019
The Yes is an artificial intelligence-based shopping platform founded in 2018 and headquartered in Burlingame, California, with additional operations in New York City. The company aims to transform the e-commerce landscape by leveraging AI technology to enhance the online shopping experience. By focusing on innovative solutions, The Yes seeks to attract critical thinkers who can contribute to reimagining the rules of online retail. The platform is dedicated to creating a dynamic and engaging shopping environment for users.

Aquabyte

Series A in 2019
Founded in 2017, Aquabyte specializes in developing smart camera systems and machine learning models for aquaculture. Its solutions include real-time sea lice counting, biomass monitoring, appetite detection, and feed optimization, aiming to enhance fish farm efficiency, sustainability, and profitability.

Block Renovation

Series A in 2019
Block Renovation operates a renovation platform that unites design, sourcing, and construction within a single process to simplify home makeovers. The company combines architect-grade design, construction labor, and materials into a streamlined experience, enabling homeowners to plan, design, and build renovations with greater certainty around outcomes, quality, price, and timeline. By integrating design, sourcing, and project management under one roof, Block Renovation aims to improve the renovation journey for homeowners and provide contractors with a clearer, more efficient workflow.

Level

Series A in 2019
Level, operating under the name Zero Financial, Inc., is a financial technology company based in San Francisco, California, that offers a modern mobile banking experience. The company's primary products include a mobile banking application, a debit card known as Zerocard, and a checking account called Zero Checking. The app provides users with real-time insights into their finances, displaying debit card purchases alongside other transactions to help manage their budgets effectively. Unlike traditional banking options, Zerocard combines the convenience of a debit card with the benefits of a credit card, offering users unlimited cash back rewards ranging from 1.0% to 3.0% on expenditures, as well as competitive annual interest rates on account balances. Level aims to eliminate common banking fees, striving to simplify personal finance management for its users.

Reneo Pharmaceuticals

Series A in 2019
Reneo Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company based in San Diego, California, dedicated to developing therapies for patients with rare genetic mitochondrial diseases. These conditions are characterized by deficits in cellular metabolism and energy production, often leading to significant health challenges. The company is focused on creating treatments that improve mitochondrial function, preserve muscle integrity, and enhance the overall quality of life for affected individuals. Its lead product candidate, REN001, is an oral medication designed to modulate genes critical to the production of adenosine triphosphate (ATP), the primary energy source for cellular processes. Founded in 2014, Reneo aims to address the unmet needs of patients suffering from orphan metabolic diseases linked to mitochondrial dysfunction.

ARRIS

Series A in 2019
ARRIS specializes in developing additive molding technology for manufacturing large-scale 3D-aligned continuous fiber thermoplastic composite parts. Its innovative process combines aligned fibers, electronics, and metallic components within topology-optimized structures, serving industries such as aerospace, automotive, and consumer products.

Spyglass Ophthalmics

Series A in 2019
Spyglass Ophthalmics, Inc. is a company based in Mission Viejo, California, specializing in the development of ophthalmic therapeutic devices. Founded in 2019, Spyglass focuses on creating innovative solutions to enhance vision and eye care for patients. The company's products target unmet needs in areas such as cataract treatment, lens replacement, and other chronic ophthalmic diseases. By providing these devices, Spyglass aims to ensure that patients receive quality eye treatment at an affordable cost.

AppSheet

Series A in 2019
AppSheet is an intelligent no-code platform established in 2014 and headquartered in Seattle, Washington. It enables business users to create powerful, code-free applications by leveraging their business data. The platform connects with various data sources, including cloud storage services and relational databases, allowing for quick generation of customizable applications. These applications can incorporate advanced features such as offline access, workflow rules, and machine learning capabilities, and they are designed to run seamlessly on web, iOS, Android, and messaging platforms. AppSheet's focus on simplifying app development helps organizations meet IT governance and security requirements while enhancing the end-user experience through rich, custom software solutions.

Metabase

Series A in 2019
Founded in 2014, Metabase is an open-source analytics and business intelligence application that enables users to create dashboards and share insights. Its platform offers professional services such as managed hosting and custom implementation assistance.

THE WELL

Series A in 2019
THE WELL operates a wellness club and spa, offering personalized health plans tailored by doctors and practitioners. It combines Western medicine with Eastern healing practices, providing members with integrative care and customized plans.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.